Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish the clinical superiority and the safety of topical
pexiganan cream 0.8% plus standard local wound care as compared to placebo cream plus
standard local wound care, in the treatment of mildly infected diabetic foot ulcers.